HFS
FOLD

Hantz Financial Services’s Amicus Therapeutics FOLD Stock Holding History

Hantz Financial Services’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-132
Closed -$2K – 2529
2026
Q1 		$2K Hold
132
– – ﹤0.01% 2283
2025
Q4 		$2K Buy
+132
New +$1.3K ﹤0.01% 2234
2024
Q4 		– Sell
-100
Closed -$1K – 1132
2024
Q3 		$1K Hold
100
– – ﹤0.01% 1018
2024
Q2 		$1K Hold
100
– – ﹤0.01% 1001
2024
Q1 		$1K Hold
100
– – ﹤0.01% 1120
2023
Q4 		$1K Buy
+100
New +$1.14K ﹤0.01% 1072

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Hantz Financial Services's FOLD Position: Q2 2026 in Review

Hantz Financial Services sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 132 shares — an estimated $2K sold.

Hantz Financial Services first reported a position in FOLD in Q4 2023 and held it in 6 quarters. The position peaked at $2K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Hantz Financial Services reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Hantz Financial Services sold 132 Amicus Therapeutics shares in Q2 2026, an estimated $2K.
  • Hantz Financial Services first reported a position in Amicus Therapeutics in Q4 2023 and held it in 6 quarters.
  • Hantz Financial Services's Amicus Therapeutics position peaked at $2K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.